FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Lehrke

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Geographic Areas

Germany

Co-author Network

Publications

TOP 3
S Nölting; M Nicolaus; Jürgen Behr; R Baumgartner; H Mete; Peter Boekstegers; K Herrmann; Daniel Theisen; Michael Lehrke; Burkhard Göke; Jörg Schirra; Christoph J Auernhammer
[Progressive dyspnoea in two patients with carcinoid syndrome].
Michael Vogeser; Peter Schwandt; Gerda-Maria Haas; Uli C Broedl; Michael Lehrke; Klaus G Parhofer
BMI and hyperinsulinemia in children.
Michael Lehrke; Alexander Becker; Martin Greif; Renee Stark; Rüdiger P Laubender; Franz von Ziegler; Corinna Lebherz; Janine Tittus; Maximilian Reiser; Hans-Christoph Becker; Burkhard Göke; Alexander W Leber; Klaus G Parhofer; Uli C Broedl
Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Lehrke (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: S Nölting; M Nicolaus; Jürgen Behr; R Baumgartner; H Mete; Peter Boekstegers; K Herrmann; Daniel Theisen; Michael Lehrke; Burkhard Göke; Jörg Schirra; Christoph J Auernhammer
[Progressive dyspnoea in two patients with carcinoid syndrome].
Der Internist 2010;51(11):1439-45.
2009: Michael Vogeser; Peter Schwandt; Gerda-Maria Haas; Uli C Broedl; Michael Lehrke; Klaus G Parhofer
BMI and hyperinsulinemia in children.
Clinical biochemistry 2009;42(13-14):1427-30.
2009: Michael Lehrke; Alexander Becker; Martin Greif; Renee Stark; Rüdiger P Laubender; Franz von Ziegler; Corinna Lebherz; Janine Tittus; Maximilian Reiser; Hans-Christoph Becker; Burkhard Göke; Alexander W Leber; Klaus G Parhofer; Uli C Broedl
Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.
European journal of endocrinology / European Federation of Endocrine Societies 2009;161(2):339-44.
2009: Michael Lehrke; Martin Greif; Uli C Broedl; Corinna Lebherz; Rüdiger P Laubender; Alexander Becker; Franz von Ziegler; Janine Tittus; Maximilian Reiser; Hans-Christoph Becker; Burkhard Göke; Gerhard Steinbeck; Alexander Leber; Klaus G Parhofer
MMP-1 serum levels predict coronary atherosclerosis in humans.
Cardiovascular diabetology 2009;8():50.
2009: Uli C Broedl; Corinna Lebherz; Michael Lehrke; Renee Stark; Martin Greif; Alexander Becker; Franz von Ziegler; Janine Tittus; Maximilian Reiser; Hans-Christoph Becker; Burkhard Göke; Klaus G Parhofer; Alexander W Leber
Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques.
PloS one 2009;4(3):e4733.
2008: Katja Rabe; Michael Lehrke; Klaus G Parhofer; Uli C Broedl
Adipokines and insulin resistance.
Molecular medicine (Cambridge, Mass.) 2008;14(11-12):741-51.
2008: Michael Lehrke; Astrid Konrad; Veronika Schachinger; Cornelia Tillack; Frank Seibold; Renee Stark; Iklaus G Parhofer; Uli C Broedl
CXCL16 is a surrogate marker of inflammatory bowel disease.
Scandinavian journal of gastroenterology 2008;43(3):283-8.
2008: Michael Lehrke; Uli C Broedl; Ingeborg M Biller-Friedmann; Michael Vogeser; Volkmar Henschel; Kirsten Nassau; Burkhard Göke; Erich Kilger; Klaus G Parhofer
Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions.
Critical care (London, England) 2008;12(6):R157.
2007: Astrid Konrad; Michael Lehrke; Veronika Schachinger; Frank Seibold; Renee Stark; Thomas Ochsenkühn; Klaus G Parhofer; Burkhard Göke; Uli C Broedl
Resistin is an inflammatory marker of inflammatory bowel disease in humans.
European journal of gastroenterology & hepatology 2007;19(12):1070-4.
2007: Uli C Broedl; Veronika Schachinger; Arno Lingenhel; Michael Lehrke; Renee Stark; Frank Seibold; Burkhard Göke; Florian Kronenberg; Klaus G Parhofer; Astrid Konrad-Zerna
Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease.
Inflammatory bowel diseases 2007;13(4):391-7.
2006: Carsten Otto; B Otto; Burkhard Göke; A F H Pfeiffer; Michael Lehrke; M Vogeser; J Spranger; Klaus G Parhofer
Increase in adiponectin levels during pioglitazone therapy in relation to glucose control, insulin resistance as well as ghrelin and resistin levels.
Journal of endocrinological investigation 2006;29(3):231-6.
2006: Uli C Broedl; Michael Lehrke; Elisabeth Fleischer-Brielmaier; Anne B Tietz; Jutta M Nagel; Burkhard Göke; Peter Lohse; Klaus G Parhofer
Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome.
Cardiovascular diabetology 2006;5():11.
2003: Klaus Empen; H Christian Geiss; Michael Lehrke; Carsten Otto; Peter Schwandt; Klaus G Parhofer
Effect of atorvastatin on lipid parameters, LDL subtype distribution, hemorrheological parameters and adhesion molecule concentrations in patients with hypertriglyceridemia.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2003;13(2):87-92.
2002: Carsten Otto; Michael Lehrke; Burkhard Göke
Novel insulin sensitizers: pharmacogenomic aspects.
Pharmacogenomics 2002;3(1):99-116.